AboutBlogFDA EmployeeOver 40,000+ FDA inspection documents: 483s, EIRs, 483Rs

483 North China Pharmaceutical Huasheng, Aug 2018

$179 - Available for instant download

FDA investigators audited the North China Pharmaceutical Huasheng - Shijiazhuang, China facility and issued inspectional observation (via FDA 483) on 10 Aug 2018.

Product Details

  • Inspection end: 10 Aug 2018
  • Location: Shijiazhuang, China
  • FEI: 3003001488
North China Pharmaceutical Huasheng FDA inspection 483 Aug 2018

Related Products